Clinical Characteristics and Outcomes of Invasive Pulmonary Aspergillosis in Patients with Influenza Compared to COVID-19: A Retrospective Cohort Analysis - Takeaways - MDSpire

Clinical Characteristics and Outcomes of Invasive Pulmonary Aspergillosis in Patients with Influenza Compared to COVID-19: A Retrospective Cohort Analysis

  • By

  • Renwen Zhang

  • Jun Liu

  • Ran Li

  • Li Gu

  • April 24, 2026

  • 0 min

Share

  • 1

    The study compared clinical characteristics and outcomes of invasive pulmonary aspergillosis in patients with influenza and COVID-19.

  • 2

    CAPA patients exhibited significantly lower lymphocyte counts and higher corticosteroid use compared to IAPA patients.

  • 3

    Respiratory bacterial co-infections were more prevalent in the CAPA group, indicating a higher risk of complications.

  • 4

    The risk of death within 14 days of IPA diagnosis was nearly five times greater in the CAPA group than in the IAPA group.

  • 5

    Findings emphasize the need for early therapeutic intervention in CAPA patients due to their increased mortality risk.

Original Source(s)

Clinical Characteristics and Outcomes of Invasive Pulmonary Aspergillosis in Patients with Influenza Compared to COVID-19: A Retrospective Cohort Analysis

  • by Renwen Zhang, Jun Liu, Ran Li, Li Gu

  • April 24, 2026

Related Content

SARS-CoV-2 and reproductive system: a scientometric study

Hantavirus Outbreak Revives COVID-Era False Health Claims — The Monitor

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.